ATROPINE SULFATE INJECTION USP

Pfizer Canada Ulc🇨🇦 Health Canada

Approval Id: 6cc25679fe93e8dc
Drug Approval Canada Name: ATROPINE SULFATE INJECTION USP
Product Name: ATROPINE SULFATE INJECTION USP
Status: Cancelled Post Market
Status Date: 2021-08-01
Original Market Date: 2020-03-25
Din: 02472171
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous , Intramuscular , Subcutaneous
Schedule: Prescription
Ahfs: 12:08.08
Atc Original: A03BA01 ATROPINE
Atc Name: a 03 ba 01
Aig Number: 0104748003
Company Name: Pfizer Canada Ulc
Company Address: 17300 Trans-Canada Highway, Kirkland, Quebec, Canada, H9J 2M5
Company Detail Path: /organization/pfizer-canada-ulc

ATROPINE SULFATE

0.5 MG / 5 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

6cc25679fe93e8dc

Type

Standard